MedTrace Logo

Innovative Ultrasound Technology in Neuromuscular Disease

NCT02104921 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 223

Last updated 2022-03-11

No results posted yet for this study

Summary

This study is utilizing ultrasound measurement to measure neuromuscular disease status in adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that ultrasound can be utilized as a tool to determine if a disease is responding to therapy or progressing.

Conditions

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-01
Primary Completion
2020-03-01
Completion
2020-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02104921 on ClinicalTrials.gov